- Home
- STIM vs KOD Comparison
STIM vs KOD Comparison
Compare STIM & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STIM
- KOD
- Stock Information
- Founded
- STIM 2003
- KOD 2009
- Country
- STIM United States
- KOD United States
- Employees
- STIM N/A
- KOD N/A
- Industry
- STIM Medical/Dental Instruments
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STIM Health Care
- KOD Health Care
- Exchange
- STIM Nasdaq
- KOD Nasdaq
- Market Cap
- STIM 232.3M
- KOD 259.6M
- IPO Year
- STIM 2018
- KOD 2018
- Fundamental
- Price
- STIM $3.76
- KOD $3.61
- Analyst Decision
- STIM Buy
- KOD Hold
- Analyst Count
- STIM 4
- KOD 3
- Target Price
- STIM $6.00
- KOD $9.00
- AVG Volume (30 Days)
- STIM 885.6K
- KOD 440.1K
- Earning Date
- STIM 05-06-2025
- KOD 05-14-2025
- Dividend Yield
- STIM N/A
- KOD N/A
- EPS Growth
- STIM N/A
- KOD N/A
- EPS
- STIM N/A
- KOD N/A
- Revenue
- STIM $89,448,000.00
- KOD N/A
- Revenue This Year
- STIM $104.65
- KOD N/A
- Revenue Next Year
- STIM $10.69
- KOD N/A
- P/E Ratio
- STIM N/A
- KOD N/A
- Revenue Growth
- STIM 22.16
- KOD N/A
- 52 Week Low
- STIM $0.52
- KOD $1.92
- 52 Week High
- STIM $5.92
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- STIM 39.38
- KOD 44.47
- Support Level
- STIM $3.78
- KOD $3.46
- Resistance Level
- STIM $4.00
- KOD $3.81
- Average True Range (ATR)
- STIM 0.23
- KOD 0.40
- MACD
- STIM -0.05
- KOD -0.07
- Stochastic Oscillator
- STIM 9.09
- KOD 31.58
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.